Advanced search
Publication Cover
Infection and Drug Resistance Volume 17, 2024 - Issue
Submit an article Journal homepage
86
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+

Mateusz Szymański1 Human Anatomy Department, Medical University, Lublin, Poland;2 Intensive Care Unit, Stefan Cardinal Wyszyński District Specialist Hospital, Lublin, Poland
,
Małgorzata M Skiba2 Intensive Care Unit, Stefan Cardinal Wyszyński District Specialist Hospital, Lublin, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9637-9016
ORCID Icon,
Małgorzata Piasecka2 Intensive Care Unit, Stefan Cardinal Wyszyński District Specialist Hospital, Lublin, Poland
&
Alina Olender3 Chair and Department of Medical Microbiology, Medical University, Lublin, Poland
Pages 2307-2313 | Received 27 Feb 2024, Accepted 22 May 2024, Published online: 09 Jun 2024

References

  • Żukowska A, Hryniewicz W. Recommendations for diagnosis, therapy and antibiotic prophylaxis infections in the hospital-2020. Antybiotyki.edu.pl. Warsaw. National institute of medicines. Polish; 2023. Avaliable from: https://antybiotyki.edu.pl/wp-content/uploads/2021/03/rekomendacje-diagnostyki-terapii 2021.03.02.pdf. Accessed May 24.
  • Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-Resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics. 2023;12(2):234. doi:10.3390/antibiotics12020234
  • Taha R, Kader O, Shawky S, et al. Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope. Ann Clin Microbiol Antimicrob. 2023;22(1):21. doi:10.1186/s12941-023-00573-3
  • Nordmann P, Gniadkowski M, Giske CG, et al. European network on carbapenemases. identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2012;18(5):432–438. doi:10.1111/j.1469-0691.2012.03815.x
  • Miriagou V, Cornaglia G, Edelstein M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010;16(2):112–122. doi:10.1111/j.1469-0691.2009.03116.x
  • Swaminathan S, Routray A, Mane A. Early and appropriate use of ceftazidime-avibactam in the management of multidrug-resistant gram-negative bacterial infections in the Indian scenario. Cureus. 2022;14(8):e28283. doi:10.7759/cureus.28283
  • Fasciana T, Ciammaruconi A, Gentile B, et al. draft genome sequence and biofilm production of a carbapenemase-producing Klebsiella pneumoniae (KpR405) Sequence Type 405 Strain Isolated in Italy. Antibiotics. 2021;10:560. doi:10.3390/antibiotics10050560
  • Zhen S, Wang H, Feng S. Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections. Infection. 2022;50(6):1409–1423. doi:10.1007/s15010-022-01876-x
  • Isler B, Aslan AT, Akova M, et al. Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections Pneumoniae Infections. Expert Rev Anti Infect Ther. 2022;20(11):1389–1400. doi:10.1080/14787210.2022.2128764
  • Xu C, Zeng F, Huang Y, et al. Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat pseudomonas aeruginosa. Int J Antimicrob Agents. 2023;25:107021. doi:10.1016/j.ijantimicag.2023.107021
  • Eucast.org. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.1, 2023; 2023. Avaliable from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.1_Breakpoint_Tables.pdf. Accessed May 24, 2024.
  • Khan A, Erickson SG, Pettaway C, et al. Evaluation of susceptibility testing methods for aztreonam and ceftazidime-avibactam combination therapy on extensively drug-resistant gram-negative organisms. Antimicrob Agents Chemother. 2021;65(11):e0084621. doi:10.1128/AAC.00846-21
  • Castón JJ, Cano A, Pérez-Camacho I, et al. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study). J Antimicrob Chemother. 2022;77(5):1452–1460. doi:10.1093/jac/dkac049
  • Zalas-Więcek P, Prażyńska M, Pojnar Ł, et al. Ceftazidime/avibactam and other commonly used antibiotics activity against enterobacterales and pseudomonas aeruginosa isolated in Poland in 2015–2019. Infect Drug Resist. 2022;15:1289–1304. doi:10.2147/IDR.S344165
  • Chen Y, Huang HB, Peng JM, et al. Efficacy and safety of ceftazidime-avibactam for the treatment of carbapenem-resistant enterobacterales bloodstream infection: a systematic review and meta-analysis. Microbiol Spectr. 2022;10(2):e0260321. doi:10.1128/spectrum.02603-21
  • Giamarellou H, Karaiskos I. Current and potential therapeutic options for infections caused by difficult-to-treat and pandrug resistant gram-negative bacteria in critically ill patients. Antibiotics. 2022;11(8):1009. doi:10.3390/antibiotics11081009
  • Paul M, Carrara E, Retamar P, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521–547. doi:10.1016/j.cmi.2021.11.025
  • Bassetti M, Vena A, Giacobbe DR, et al. Management of infections caused by multidrug-resistant gram-negative pathogens: recent advances and future directions. Arch Med Res. 2021;52(8):817–827. doi:10.1016/j.arcmed.2021.09.002
  • Bassetti M, Mularoni A, Giacobbe DR, et al. New antibiotics for hospital-acquired pneumonia and ventilator-associated pneumonia. Semin Respir Crit Care Med. 2022;43(2):280–294. doi:10.1055/s-0041-1740605

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.